---
title: "Cathie Wood is buying this up-and-coming biotech stock. Should you follow her lead?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293245844.md"
description: "Beam Therapeutics' growing pipeline could reward patient investors."
datetime: "2026-07-20T18:43:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293245844.md)
  - [en](https://longbridge.com/en/news/293245844.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293245844.md)
---

# Cathie Wood is buying this up-and-coming biotech stock. Should you follow her lead?

Beam Therapeutics' growing pipeline could reward patient investors.

### Related Stocks

- [BEAM.US](https://longbridge.com/en/quote/BEAM.US.md)

## Related News & Research

- [Beam Therapeutics announces press release availability](https://longbridge.com/en/news/293603857.md)
- [05:24 ETThreatMark positioned as a Leader in the SPARK Matrix™: Behavioral Biometrics and Device Intelligence Solutions 2026 by QKS Group](https://longbridge.com/en/news/294335348.md)
- [09:04 ETInsideTracker Unveils Source-Agnostic Blood Data Processing Across Nearly 120 Biomarkers](https://longbridge.com/en/news/294212904.md)
- [Green Arrow Capital, Iron Re sell Italy biomethane group BG Holding to Bankinter Investment, Plenium Partners](https://longbridge.com/en/news/294326573.md)
- [UBS Sticks to Its Hold Rating for bioMerieux (0RUG)](https://longbridge.com/en/news/294192303.md)